BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
KLK3
,
T cell receptor signaling pathway
,
Arthritis
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
heparin cofactor II
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal liver
Liver
Trigeminal ganglia
Superior cervical ganglion
Basophil of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Mannose 2, 3, 4, 5, 6-O-pentasulfate (MPS): a partial activator of human heparin cofactor II with an…
Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterior…
Identification and characterization of a novel isoform of heparin cofactor II in human liver.
Alpha-2-macroglobulin and heparin cofactor II and the vulnerability of carotid atherosclerotic plaqu…
A Hexasaccharide Containing Rare 2-O-Sulfate-Glucuronic Acid Residues Selectively Activates Heparin …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitor…
Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.
Safety and Dosing Evaluation of REG1 Anticoagulation System
Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ